AI Plus Ovarian Suppression Yields Benefit in High-Risk Premenopausal Breast Cancer Patients

Premenopausal women with hormone receptor-positive, HER2-negative breast cancer and a high risk of recurrence who are treated with an aromatase inhibitor plus ovarian function suppression may gain 10 to 15 percent improvement in freedom from distant...
31-May-2018 3:30 PM EDT Add to Favorites

Blood Test Shows Potential for Early Detection of Lung Cancer

A test that analyzes free-floating DNA in the blood may be able to detect early-stage lung cancer, a preliminary report from the ongoing Circulating Cell-Free Genome Atlas (CCGA) study suggests.
31-May-2018 3:30 PM EDT Add to Favorites

Philips and Dana-Farber operationalize and scale Clinical Pathways

he Dana-Farber Clinical Pathways will be deployed through the Philips IntelliSpace Oncology Platform, providing clinical decision support to physicians via a patient-centric solution.
31-May-2018 9:00 AM EDT Add to Favorites

Study Reveals That Many Oncologists Recommend Medical Marijuana Clinically Despite Not Feeling Sufficiently Knowledgeable to Do So

While a wide majority of oncologists do not feel informed enough about medical marijuana’s utility to make clinical recommendations, most do in fact conduct discussions on medical marijuana in the clinic and nearly half recommend it to their...
1-May-2018 5:00 PM EDT Add to Favorites

Genomic Analysis Unravels Complexities of the Most Common Form of Lymphoma and Enables Personalized Treatment

The majority of patients with diffuse large B cell lymphoma (DLBCL) can be treated effectively. However, people whose disease recurs face a shortage of good options, especially because the disease is driven by a complicated mix of genetic...
26-Apr-2018 5:05 PM EDT Add to Favorites

In Multiple Myeloma, Different Types of Blood Biopsies Match Up Well with Bone Marrow Tests

Bone marrow biopsies are the gold standard for diagnosing and monitoring the progression of multiple myeloma, but these procedures are far too invasive to perform at every patient visit. Scientists from the Dana-Farber Cancer Institute and the Broad...
26-Apr-2018 4:15 PM EDT Add to Favorites

Dana-Farber’s Bank of Patient-Derived Tumor Xenografts Gets Major Boost From Novartis

Dana-Farber Cancer Institute is establishing a bank of patient-derived xenograft models of more than 750 human tumors.
7-Mar-2018 5:00 AM EST Add to Favorites

Cognitive Decline Prevalent Among Elderly Patients with Hematologic Cancers, Study Finds

A sizable percentage of elderly patients with blood-related cancers such as leukemia and multiple myeloma are apt to show signs of diminished cognitive functioning
6-Mar-2018 11:05 AM EST Add to Favorites